Hemophilia diagnosis at birth

Sara Pavao learned that her sons, Kapono and Duke, had hemophilia shortly after they were born. The disorder, which affects the body's ability to form blood clots, left them vulnerable to severe bruising from minor injuries.

Freedom through new treatments

Now, the brothers engage in high-energy activities like surfing, dirt biking, and jujitsu. These activities were once unthinkable for hemophiliac children, but recent medical advancements have made them possible.

Medical breakthroughs in hemophilia

The development of non-factor replacement treatments has transformed the management of hemophilia. These medications prevent dangerous bleeds without requiring frequent infusions of clotting factors. Gene therapy also offers a one-time treatment for some patients, though its long-term effectiveness remains uncertain.

Effectiveness and limitations of new drugs

Leslie Raffini, a specialist at the Children’s Hospital of Philadelphia, calls these advancements one of the greatest successes of modern medicine. However, she notes that while the new treatments significantly reduce the risk of bleeding, they do not eliminate it entirely.

Impact on daily life

For the Pavao family, the change in treatment has made life more normal. Traveling no longer requires carrying large amounts of medication, and the boys can participate in activities that were once considered too risky.

Understanding hemophilia

Hemophilia is a genetic disorder that affects the clotting process. It is caused by a deficiency in clotting factors, specifically factor VIII in hemophilia A and factor IX in hemophilia B. The condition is more common in men because the responsible genes are on the X chromosome.

Early diagnosis and treatment

Most children with hemophilia are diagnosed before age two, often after abnormal bleeding following a circumcision or minor injury. Without treatment, the condition can lead to severe disabilities or even early death.

History of hemophilia treatment

For decades, the standard treatment involved replacing missing clotting factors through infusions. However, this approach carried risks, including the spread of viruses like HIV through contaminated blood products in the 1980s.

Advancements in factor replacement

Synthetic clotting factors replaced plasma-derived products in the 1990s, making treatment safer. Prophylactic use of these factors has become a standard practice to prevent bleeds, though they still have limitations in terms of duration of protection.

Challenges with factor replacement

Some patients develop inhibitors—antibodies that neutralize the treatment—making it ineffective. Immunotolerance therapy can help in some cases, but not all patients respond successfully.

Non-factor replacement treatments

These newer treatments promote clotting without replacing the missing factor. They offer more consistent protection and have significantly reduced the number of bleeding events in many patients.

Gene therapy as a breakthrough

Gene therapy, such as Hemgenix, allows some patients to produce their own clotting factor. While it shows promise, its effectiveness varies, and long-term outcomes are still being studied.

Future of gene therapy

Researchers are working to improve gene therapy's reliability and effectiveness. Some are exploring genome editing to correct the underlying genetic mutations causing hemophilia.

Risks of new treatments

Despite their benefits, these treatments come with risks. Gene therapy can cause liver inflammation, and some non-factor replacement drugs may increase the risk of dangerous blood clots.

Lifestyle and activity choices

Doctors advise people with hemophilia to avoid high-impact sports like football or ice hockey. However, many patients now lead active lives with proper treatment.

Real-life examples of active hemophiliacs

Carson Cusimano, a hemophiliac with hemophilia A, competes in kart racing. His mother administers weekly infusions, allowing him to live an active lifestyle.

Parental perspective and future hopes

Sara Pavao encourages her sons to participate in activities they enjoy, and she remains hopeful for future advancements that may one day eliminate the need for treatment altogether.